Insurance implications for individuals with a high risk of breast and ovarian cancer in Europe.
Morrison
P J
PJ
Northern Ireland Regional Medical Genetics Centre, Belfast City Hospital Trust, UK. p.morrison@cableol.co.uk
Steel
C M
CM
Vasen
H F
HF
Eccles
D
D
Evans
D G
DG
Møller
P
P
Hodgson
S
S
Stoppa-Lyonnet
D
D
Chang-Claude
J
J
Caligo
M
M
Olah
E
E
Haites
N E
NE
Nevin
N C
NC
D001943:Breast Neoplasms / Q000191:economics* / Q000453:epidemiology / Q000235:genetics; D005060:Europe / Q000453:epidemiology; D005260:Female; D005544:Forecasting; D005820:Genetic Testing / Q000191:economics / Q000331:legislation & jurisprudence*; D017408:Guidelines as Topic; D006801:Humans; D007348:Insurance, Health / Q000331:legislation & jurisprudence; D008297:Male; D009386:Neoplastic Syndromes, Hereditary / Q000191:economics* / Q000453:epidemiology / Q000235:genetics; D016134:Organizational Policy; D010051:Ovarian Neoplasms / Q000191:economics* / Q000453:epidemiology / Q000235:genetics; D011287:Prejudice; D011639:Public Opinion; D012306:Risk; D018570:Risk Assessment; D006113:United Kingdom